British sprinter Nigel Levine suspended for 4 years after failing the drugs test

To optimise for archiving, the original image and related documents associated with this article have been removed.

Nigel Levine, an elite athlete, who has competed at the Olympic Games, European and World Championships was provisionally suspended in February when found to have tested positive for the asthma drug clenbuterol.

Widely used to treat asthma, and other breathing disorders, clenbuterol has also been abused by athletes and bodybuilders to burn fat and boost aerobic capacity, hence its place on the World Anti-Doping Agency's prohibited list.

Levine was charged with an ADRV pursuant to Article 2.1 of the Anti-Doping Rules – “Presence of a Prohibited Substance or its Metabolites or Markers in an Athlete’s Sample"

UKAD stated that Levine’s ban will be backdated to December 13 2017 and run until December 12 2021.

Please click here to view UKAD's the full judgement.

You may also like

View All

Los Angeles 2028 Olympic organisers generated over $2 billion in commercial revenue so far

The Los Angeles 2028 Olympic and Paralympic Games organising committee have generated over $2 billion in domestic sponsorship revenue so far, meaning it may become one of the most commercially successful Olympics in history

Read More

World Athletics v Sheila Chelangat

A decision in the case of World Athletics (WA) against Sheila Chelangat (the Athlete) has been issued by the WA Disciplinary and Appeals Tribunal (DAT)

Read More

WNBA proposes $1 million base salary along with compensation tied more closely to the league’s revenue

In the Women’s National Basketball Association’s latest collective bargaining agreement update, it has proposed a $1 million base salary for athletes on max deals, which is the largest contract a player can sign, partly determined by their years of service in the league, and has agreed to increase compensation in line with revenue growth

Read More